| Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy Subjects (NCT01490099) | Novo Nordisk A/S | 2006-08-01 |
| Effect of Liraglutide on Heart Frequency in Healthy Volunteers (NCT01516255) | Novo Nordisk A/S | 2006-07-01 |
| Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands (NCT01536626) | Novo Nordisk A/S | 2006-06-09 |
| Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers (NCT01538511) | Novo Nordisk A/S | 2006-06-05 |
| Comparison of NovoFine® Needles (4 mm vs. 6 mm) (NCT00343343) | Novo Nordisk A/S | 2006-06-01 |
| Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers (NCT01489644) | Novo Nordisk A/S | 2006-06-01 |
| Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers (NCT01490658) | Novo Nordisk A/S | 2006-06-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00333151) | Novo Nordisk A/S | 2006-05-01 |
| Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes (NCT01545791) | Novo Nordisk A/S | 2006-05-01 |
| Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes (NCT00322257) | Novo Nordisk A/S | 2006-05-01 |
| Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma (NCT00323570) | Novo Nordisk A/S | 2006-05-01 |
| Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH (NCT01518166) | Novo Nordisk A/S | 2006-05-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00331851) | Novo Nordisk A/S | 2006-05-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00318422) | Novo Nordisk A/S | 2006-05-01 |
| Bioequivalence of Two Insulatard® Formulations in Healthy Subjects (NCT01486901) | Novo Nordisk A/S | 2006-05-01 |
| Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects (NCT01486888) | Novo Nordisk A/S | 2006-05-01 |
| To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together (NCT00318461) | Novo Nordisk A/S | 2006-05-01 |
| Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects (NCT01561417) | Novo Nordisk A/S | 2006-04-01 |
| The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins (NCT00313742) | Novo Nordisk A/S | 2006-04-01 |
| Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea. (NCT00313001) | Novo Nordisk A/S | 2006-04-01 |
| Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes (NCT01536028) | Novo Nordisk A/S | 2006-04-01 |
| Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes (NCT00318786) | Novo Nordisk A/S | 2006-04-01 |
| Comparison of Two Liraglutide Formulations in Healthy Subjects (NCT01515579) | Novo Nordisk A/S | 2006-04-01 |
| Observational Prospective Study on Patients Treated With Norditropin® (NCT00960128) | Novo Nordisk A/S | 2006-04-01 |
| Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency (NCT01507454) | Novo Nordisk A/S | 2006-04-01 |
| Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function (NCT01507389) | Novo Nordisk A/S | 2006-03-01 |
| An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus (NCT01542424) | Novo Nordisk A/S | 2006-03-01 |
| Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL) (NCT01530048) | Novo Nordisk A/S | 2006-03-01 |
| Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment (NCT01548235) | Novo Nordisk A/S | 2006-02-01 |
| To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c (NCT00294723) | Novo Nordisk A/S | 2006-02-01 |
| Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes (NCT00282451) | Novo Nordisk A/S | 2006-02-01 |
| Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes (NCT01536639) | Novo Nordisk A/S | 2006-01-01 |
| Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers (NCT01515592) | Novo Nordisk A/S | 2006-01-01 |
| Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes (NCT01486875) | Novo Nordisk A/S | 2006-01-01 |
| Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes (NCT01536652) | Novo Nordisk A/S | 2006-01-01 |
| Factor VIIa in Acute Intracerebral Haemorrhage (NCT00266006) | Novo Nordisk A/S | 2006-01-01 |
| Efficacy and Safety of Levemir® Used as Basal Insulin (NCT01548248) | Novo Nordisk A/S | 2006-01-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec (NCT01865279) | Novo Nordisk A/S | 2005-12-01 |
| Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes (NCT00267683) | Novo Nordisk A/S | 2005-12-01 |
| Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography (NCT01561924) | Novo Nordisk A/S | 2005-11-01 |
| Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes (NCT01511692) | Novo Nordisk A/S | 2005-11-01 |
| Comparison of Two Insulin Detemir Formulations in Healthy Volunteers (NCT01498926) | Novo Nordisk A/S | 2005-11-01 |
| Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State (NCT01562457) | Novo Nordisk A/S | 2005-11-01 |
| Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs (NCT01486862) | Novo Nordisk A/S | 2005-10-01 |
| Treatment of Congenital Factor VII Deficiency (NCT01779921) | Novo Nordisk A/S | 2005-10-01 |
| Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding (NCT00184548) | Novo Nordisk A/S | 2005-10-01 |
| Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass (NCT02239146) | Novo Nordisk A/S | 2005-10-01 |
| Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 Diabetes (NCT00419718) | Novo Nordisk A/S | 2005-10-01 |
| Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes (NCT00264901) | Novo Nordisk A/S | 2005-10-01 |
| Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus (NCT01709929) | Novo Nordisk A/S | 2005-10-01 |
| Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes (NCT00274274) | Novo Nordisk A/S | 2005-09-01 |
| Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs (NCT00491725) | Novo Nordisk A/S | 2005-09-01 |
| NovoLet® Acceptance Study Within the Hospital Practise in Indonesia (NCT01492205) | Novo Nordisk A/S | 2005-09-01 |
| Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan (NCT01497587) | Novo Nordisk A/S | 2005-08-01 |
| Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function (NCT01508806) | Novo Nordisk A/S | 2005-08-01 |
| Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes (NCT00184561) | Novo Nordisk A/S | 2005-07-01 |
| Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe (NCT00127296) | Novo Nordisk A/S | 2005-07-01 |
| Novofine Autocover Safety Needle Versus BD Safety Glide (NCT00121355) | Novo Nordisk A/S | 2005-07-01 |
| Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction (NCT00519844) | Novo Nordisk A/S | 2005-07-01 |
| Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis (NCT01502137) | Novo Nordisk A/S | 2005-06-01 |
| A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump (NCT00115973) | Novo Nordisk A/S | 2005-06-01 |
| Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes (NCT00117780) | Novo Nordisk A/S | 2005-06-01 |
| Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers (NCT01487811) | Novo Nordisk A/S | 2005-05-01 |
| Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes (NCT00184613) | Novo Nordisk A/S | 2005-05-01 |
| Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes (NCT01497574) | Novo Nordisk A/S | 2005-05-01 |
| Recombinant Factor VIIa in Acute Intracerebral Haemorrhage (NCT00127283) | Novo Nordisk A/S | 2005-05-01 |
| Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (NCT01604161) | Novo Nordisk A/S | 2005-05-01 |
| Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy (NCT01487304) | Novo Nordisk A/S | 2005-04-01 |
| Evaluating the Use of Two Different Needles in Subjects With Diabetes (NCT00569426) | Novo Nordisk A/S | 2005-04-01 |
| Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes (NCT00184574) | Novo Nordisk A/S | 2005-04-01 |
| Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes (NCT00504673) | Novo Nordisk A/S | 2005-04-01 |
| Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes (NCT00106366) | Novo Nordisk A/S | 2005-03-01 |
| Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms (NCT00108849) | Novo Nordisk A/S | 2005-03-01 |
| Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women (NCT01477632) | Novo Nordisk A/S | 2005-03-01 |
| Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes (NCT00104182) | Novo Nordisk A/S | 2005-02-01 |
| Comparison of Three Liraglutide Formulations in Healthy Volunteers (NCT01514487) | Novo Nordisk A/S | 2005-01-13 |
| Surveillance Study of NovoRapid® for New Drug Re-examination (NCT01490112) | Novo Nordisk A/S | 2005-01-01 |
| Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury (NCT00123591) | Novo Nordisk A/S | 2005-01-01 |
| Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes (NCT00097877) | Novo Nordisk A/S | 2005-01-01 |
| Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes (NCT00154414) | Novo Nordisk A/S | 2005-01-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00154401) | Novo Nordisk A/S | 2005-01-01 |
| Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart (NCT00494988) | Novo Nordisk A/S | 2004-12-01 |
| Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle (NCT01024218) | Novo Nordisk A/S | 2004-12-01 |
| Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese (NCT01620450) | Novo Nordisk A/S | 2004-11-20 |
| Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes (NCT00184600) | Novo Nordisk A/S | 2004-11-01 |
| Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) (NCT00184730) | Novo Nordisk A/S | 2004-11-01 |
| Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury (NCT00124293) | Novo Nordisk A/S | 2004-10-06 |
| INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study (NCT00101751) | Novo Nordisk A/S | 2004-10-01 |
| Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents (NCT00097071) | Novo Nordisk A/S | 2004-10-01 |
| Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. (NCT00184626) | Novo Nordisk A/S | 2004-09-10 |
| Post Marketing Surveillance Study of Biphasic Insulin Aspart 30 (NCT01536613) | Novo Nordisk A/S | 2004-09-01 |
| Efficacy Study of IL-21 to Treat Metastatic Melanoma (NCT00336986) | Novo Nordisk A/S | 2004-09-01 |
| Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes (NCT00095082) | Novo Nordisk A/S | 2004-09-01 |
| Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes (NCT00097084) | Novo Nordisk A/S | 2004-09-01 |
| Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes (NCT01536600) | Novo Nordisk A/S | 2004-09-01 |
| Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes (NCT01542463) | Novo Nordisk A/S | 2004-09-01 |
| Growth Hormone Treatment in Children Born Small for Gestational Age (SGA) (NCT00184717) | Novo Nordisk A/S | 2004-08-18 |
| Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes (NCT00184639) | Novo Nordisk A/S | 2004-08-16 |
| Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes (NCT00097279) | Novo Nordisk A/S | 2004-08-01 |
| Use of Activated Recombinant Human Factor VII in Cardiac Surgery (NCT00154427) | Novo Nordisk A/S | 2004-08-01 |